TITLE

Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer

AUTHOR(S)
Liu, Jing; Yue, Jinbo; Xing, Ligang; Yu, Jinming
PUB. DATE
June 2013
SOURCE
Frontiers of Medicine;Jun2013, Vol. 7 Issue 2, p172
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88060319

 

Related Articles

  • Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma. Matsubara, Hisahiro // International Journal of Clinical Oncology;Dec2008, Vol. 13 Issue 6, p474 

    An esophagectomy with three-field lymph node dissection is the standard therapy for esophageal cancer in many countries, including Japan. However, the results of esophagectomy are still unsatisfactory in comparison to the results of surgical treatment for gastric cancer or colon cancer. On the...

  • Endoscopic Ultrasound Classification of Esophageal Cancer After Chemotherapy or Chemoradiotherapy. Zuccaro Jr., Gregory // American Journal of Gastroenterology;Jun2006, Vol. 101 Issue 6, p1222 

    Because of its ability to provide high resolution images of the esophageal wall and surrounding structures, Endoscopic Ultrasound (EUS) is thought to be well suited for prediction of T classification (depth of tumor invasion) and N classification (lymph node status) in patients with newly...

  • Chapter 53: Adjuvant (Postoperative) Therapy. Sanghvi, Parag; Choi, Mehee; Holland, John; Thomas Jr., Charles R. // Esophageal Cancer: Principles & Practice;2009, p401 

    Chapter 53 of the book "Esophageal Cancer: Principles and Practice," edited by Blair A. Jobe, Charles R. Thomas, and John G. Hunter is presented. It presents a review of the significance of neoadjuvant and adjuvant chemoradiotherapy (CRT) in treating advanced resectable esophageal cancer. It...

  • Esophageal cancer treated by endoscopic submucosal dissection after neoadjuvant chemoradiotherapy: a case report. Jang Hwan Lim; Sang Ah Lee; Gyoun Eun Kang; Jong Min Kim; Jin Kyung Park; Yun Jin Chung; Jae Kwon Jung; Chang Keun Park; Hyun Soo Kim; Dong Wook Lee // Journal of Medical Case Reports;2014, Vol. 8 Issue 1, p405 

    Introduction The treatment of esophageal cancer remains clinically challenging because of the overall poor prognosis associated with the disease. The mortality rate associated with surgical treatment is high, and the majority of diagnosed patients are old. As such, surgery is not possible in...

  • Chapter 54: Neoadjuvant Therapy. Boffa, Daniel J.; Detterbeck, Frank C. // Esophageal Cancer: Principles & Practice;2009, p407 

    Chapter 54 of the book "Esophageal Cancer: Principles and Practice," edited by Blair A. Jobe, Charles R. Thomas, and John G. Hunter is presented. It discusses the significance of neoadjuvant therapy for patients with esophageal cancer. It focuses on the randomized clinical trials comparing this...

  • Preoperative Chemoradiotherapy for Esophageal Cancer. Power, Derek G.; O'sulleabhain, Criostoir; Murphy, Thomas J.; Matzdorff, Axel C.; Juli�, David; G�mez, N�ria; Codina.-Cazador, Antoni; Van Hagen, Pieter; Van Lanschot, Joseph J. B.; Van Der Gaast, Ate // New England Journal of Medicine;8/30/2012, Vol. 367 Issue 9, p872 

    A letter to the editor is presented in response to the article "Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer" in the May 31, 2012 issue.

  • Review: Neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer.  // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p19 

    The article cites a study, conducted by V. Gebski and colleagues, which discusses how neoadjuvant chemoradiotherapy or chemotherapy given before surgery increase survival in patients with operable esophageal cancer. The study was published in an issue of the journal "Lancet Oncology." The...

  • ABSTRACTS.  // Archive of Oncology;2009, Vol. 17 Issue 2, p15 

    The article presents abstracts on medical topics which include the importance of surgery for gastric carcinoma, systemic chemotherapy for advanced pancreatic cancer and preopertive chemoradiotherapy in esophageal cancer.

  • Histopathologic Examination and Reporting of Esophageal Carcinomas Following Preoperative Neoadjuvant Therapy: Practical Guidelines and Current Issues. Fuju Chang; Harriet Deere; Ula Mahadeva; Simi George // American Journal of Clinical Pathology;Feb2008, Vol. 129 Issue 2, p252 

    Neoadjuvant chemoradiotherapy is being increasingly offered to patients with invasive esophageal carcinoma in an effort to downstage the tumor and consequently increase the rate of curative resection. A substantial amount of data has suggested that pathologic tumor regression following...

  • A Walk-and-Eat Intervention Improves Outcomes for Patients With Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy. YU-JUAN XU; JASON CHIA-HSIEN CHENG; JANG-MING LEE; PEI-MING HUANG; GUAN-HUA HUANG; CHERYL CHIA-HUI CHEN // Oncologist;Oct2015, Vol. 20 Issue 10, p1216 

    Background. Preserving functional walking capacity and nutritional status is important for patients with esophageal cancer, but no effective intervention is available, particularly during active treatment. Methods. This pilot randomized controlled trial tested the effects of a walk-and-eat...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics